Customizable BioIntelligence Ecosystem
Discovery platform for antibodies,
peptide therapeutics and vaccines
Biologics Discovery and Development
One platform. Configured to your target, modality, and stage.
MindWalk's biointelligence ecosystem integrates Bio-Native AI, deep biological data, and advanced lab research to make complex biology more computable and actionable across antibody discovery and development — therapeutic antibodies, anti-ID/anti-drug antibodies, and diagnostics. The platform is also designed for peptide therapeutics and vaccine programs. A dedicated team of scientific and technology experts works 1:1 with you, strategically adapting the platform to your program needs.
Bio-Native LensAI
Intelligence built on biological meaning, not just trained on data. LensAI links sequence, structure, function, and literature to generate deeper biological insight—showing how contextual intelligence is advancing molecular discovery.
Advanced Lab Research
As a recognized global leader in antibody discovery and development, MindWalk's advanced lab research — integrated with Bio-Native AI and deep biological data — is designed to support stronger starts, deeper context, and more informed progression toward the clinic.
Dengue vaccine
A highly conserved epitope shared across all four dengue virus serotypes identified with LensAI opens new directions in vaccine design, showing how pattern detection at scale expands what can be discovered. Explore the full story.
Epitope Mapping
Molecular precision aligned with x-ray crystallography. A recent LensAI case study shows computational insights reaching crystallographic-level accuracy for epitope mapping, highlighting how predictive context can strengthens experimental confidence.
CaseXCase
A series dedicated to LensAI in action. Each example applies explainable intelligence across discovery workflows—explore how contextual analysis supports insight and measurable outcomes.
Darwin Inspired
Our brand is shaped by the principles of Darwin’s daily walk of observation. MindWalk unites science and technology—a shared path shaped by curiosity and connection.
Customizable ecosystem
A hybrid platform built to decipher biological complexity
At a time when many companies are built around either science or technology, MindWalk is both. We unite AI, data, and advanced lab research in one integrated ecosystem—giving biologics discovery the precision, context, and speed it needs to move forward.
Bio-Native AI
Built to interpret biology from the start, LensAI™ powered by HYFT® reasons across biological context — connecting molecular, structural, and functional data to enable explainable, traceable insights across antibody discovery, epitope mapping, and complex biological systems.
Deep Data Integration
With more than 25 billion biological relationships mapped, HYFT® converts fragmented biological data into a structured, traceable knowledge graph — surfacing explainable connections across targets, sequences, and functions, with every insight linked back to its biological evidence.
Advanced Lab Research
A recognized global leader in antibody discovery and development. With 15+ client molecules advanced to the clinic, a team of science and technology experts will work 1:1 with you to identify diverse, high-value candidates.
Advancing biologics discovery worldwide
What people are saying:
“The MindWalk Rapid Prime immunization method and their downstream antibody discovery technology proved pivotal to Acumen's success, enabling timely identification of our human immunotherapeutic, sabirnetug, currently in Phase 2 clinical trials.”
Acumen Pharmaceuticals
“We partnered with MindWalk to generate specific binders against targets in autoimmunity and inflammation. Their proven expertise and customized discovery approach stood out immediately, and results from both their laboratory and LensAI platform exceeded expectations.”
GentiBio
“The B cell Select platform was central in developing our lead immunoinhibitory receptor drug candidates, which are now in phase I/II clinical trials. MindWalk's strategic approach, deep experience and technical know-how were essential to our discovery efforts.”
OncoResponse
“MindWalk’s LensAI platform, powered by HYFT technology, was central to optimizing our Pan-Amyloid Immunotherapy candidates for neurodegenerative disease. Their in silico screening, developability analysis, and protein engineering accelerated our discovery process and strengthened candidate performance.”
Amyl Therapeutics
Powered by experts
We are technologists and scientists working side by side. With deep experience in both, we deliver integrated solutions designed to shape the future of discovery.
Talk 1:1 with the team
Upcoming Events
Join us at an upcoming event.
PEGS Boston
Boston USA
May 11-15, 2026
BioIT World
Boston USA
May 19-21, 2026
Discovery and Development Europe
Berlin, Germany
Jun 15-16, 2026
HubX Ab Tx - San Francisco
San Francisco USA
Sep 1, 2026
World Bispecific Summit
Boston USA
Sep 16-17, 2026